Open-Label, Single-Dose, Randomized, Crossover Study To Estimate The Effects Of Food On The Pharmacokinetics Of Two Fesoterodine Sustained-Release Beads-In-Capsule Formulations And To Estimate The Relative Bioavailability Of One Or Both Formulations Compared To Commercial Tablet Formulation In Healthy Adult Volunteers
Phase of Trial: Phase I
Latest Information Update: 24 Jul 2012
At a glance
- Drugs Fesoterodine (Primary)
- Indications Bladder disorders
- Focus Pharmacokinetics
- 07 Jul 2012 Actual initiation date (1 May 2012) added as reported by ClinicalTrials.gov.
- 07 Jul 2012 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.